135 related articles for article (PubMed ID: 35414490)
1. Cytologic presentation and clinicopathologic correlation of Mullerian carcinosarcoma on serous fluid samples.
Wang J; Yan M; Michael C; Harbhajanka A
J Am Soc Cytopathol; 2022; 11(4):210-217. PubMed ID: 35414490
[TBL] [Abstract][Full Text] [Related]
2. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
McKnight R; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
[TBL] [Abstract][Full Text] [Related]
3. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
5. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature.
Lao XM; Chen DY; Zhang YQ; Xiang J; Guo RP; Lin XJ; Li JQ
Am J Surg Pathol; 2007 Jun; 31(6):817-26. PubMed ID: 17527068
[TBL] [Abstract][Full Text] [Related]
6. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
7. Cytological features of uterine carcinosarcoma: A retrospective study of 20 cases with an emphasis on the usefulness of endometrial cytology.
Okano K; Ishida M; Sandoh K; Mizokami T; Kita M; Okada H; Tsuta K
Diagn Cytopathol; 2019 Jun; 47(6):547-552. PubMed ID: 30706679
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
10. Serous effusion cytology in gynecologic malignant mixed müllerian tumors.
Modzelewski JR; Silverman JF; Berns LA; Sobieski MW; Finley JL
Diagn Cytopathol; 1995 Jun; 12(4):309-12. PubMed ID: 7544718
[TBL] [Abstract][Full Text] [Related]
11. Early-stage multi-differentiated gastric carcinosarcoma and post-resection local recurrence: a case report.
Shioya A; Kurose N; Mizutani K; Kumagai M; Kawaura K; Nakamura N; Kosaka T; Motono N; Uramoto H; Yamada S
Diagn Pathol; 2020 Sep; 15(1):118. PubMed ID: 32972454
[TBL] [Abstract][Full Text] [Related]
12. PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).
Holmes BJ; Gown AM; Vang R; Ronnett BM; Yemelyanova A
Int J Gynecol Pathol; 2014 Jul; 33(4):425-31. PubMed ID: 24901404
[TBL] [Abstract][Full Text] [Related]
13. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
[TBL] [Abstract][Full Text] [Related]
15. Effusion cytology of metastatic carcinosarcoma.
Kundu R; Shastri M; Gupta P; Gupta N; Srinivasan R; Dey P
Cytojournal; 2023; 20():14. PubMed ID: 37405308
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
18. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature.
Li J; Cao C; Liu P; Yan Z; Xing D; Liu A
Diagn Pathol; 2022 Oct; 17(1):76. PubMed ID: 36199118
[TBL] [Abstract][Full Text] [Related]
20. Cytology of vaginal and uterine sarcomas.
Ito E; Saito T; Suzuki T; Fujii M; Kudo R
Acta Cytol; 2004; 48(5):601-7. PubMed ID: 15471250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
